SCM
ACHV icon

Sterling Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Sterling Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78K Buy
+273
New +$1.3K ﹤0.01% 3018
2025
Q2 		– Sell
-255
Closed -$681 – 3265
2025
Q1 		$681 Sell
255
-227
-47% -$706 ﹤0.01% 2912
2024
Q4 		$1.7K Buy
482
+418
+653% +$1.89K ﹤0.01% 2822
2024
Q3 		$303 Buy
+64
New +$292 ﹤0.01% 3029

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sterling Capital Management's ACHV Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 273 shares worth $1.78K. The stake represents ﹤0.01% of the portfolio and ranks #3018 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in ACHV as recently as Q1 2025.

Sterling Capital Management first reported a position in ACHV in Q3 2024 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Sterling Capital Management held 273 shares of Achieve Life Sciences worth $1.78K as of Q2 2026.
  • Achieve Life Sciences was a new Sterling Capital Management position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3018 holding.
  • Sterling Capital Management first reported a position in Achieve Life Sciences in Q3 2024 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.